119 related articles for article (PubMed ID: 15493579)
21. C-myc amplification and cluster analysis in human gastric carcinoma.
Kozma L; Kiss I; Hajdú J; Szentkereszty Z; Szakáll S; Ember I
Anticancer Res; 2001; 21(1B):707-10. PubMed ID: 11299830
[TBL] [Abstract][Full Text] [Related]
22. EGFR, ERBB2, and KRAS mutations in Korean non-small cell lung cancer patients.
Bae NC; Chae MH; Lee MH; Kim KM; Lee EB; Kim CH; Park TI; Han SB; Jheon S; Jung TH; Park JY
Cancer Genet Cytogenet; 2007 Mar; 173(2):107-13. PubMed ID: 17321325
[TBL] [Abstract][Full Text] [Related]
23. [Rearrangement of the c-erbB2 oncogene--analysis of the gastrocolic carcinoma].
Kobayashi H; Kawamura M; Kusano M; Watanabe H; Fukuchi K; Takagi Y; Gomi K
Rinsho Byori; 1995 Jan; 43(1):51-5. PubMed ID: 7884965
[TBL] [Abstract][Full Text] [Related]
24. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
25. Association of minisatellite instability with c-myc amplification and K-ras mutation in methylcholanthrene-induced mouse sarcomas.
Niwa O; Kamiya K; Furihata C; Nitta Y; Wang Z; Fan YJ; Ninomiya Y; Kotomura N; Numoto M; Kominami R
Cancer Res; 1995 Dec; 55(23):5670-6. PubMed ID: 7585652
[TBL] [Abstract][Full Text] [Related]
26. [Point mutation at codon 12 of c-Ki-ras oncogene in human pancreatic neoplasms and normal human pancreas tissue].
Cui Q; Wang Z; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):201-5. PubMed ID: 7805165
[TBL] [Abstract][Full Text] [Related]
27. Amplification of protooncogenes in surgical specimens of human lung carcinomas.
Shiraishi M; Noguchi M; Shimosato Y; Sekiya T
Cancer Res; 1989 Dec; 49(23):6474-9. PubMed ID: 2573414
[TBL] [Abstract][Full Text] [Related]
28. A novel activating mutation of the K-ras gene in human primary colon adenocarcinoma.
Tsukuda K; Tanino M; Soga H; Shimizu N; Shimizu K
Biochem Biophys Res Commun; 2000 Nov; 278(3):653-8. PubMed ID: 11095964
[TBL] [Abstract][Full Text] [Related]
29. [Detection of Ki-ras oncogene mutations in normal mucosa, adenoma and adenocarcinoma of the colon].
Wang ZY
Zhonghua Bing Li Xue Za Zhi; 1993 Dec; 22(6):333-6. PubMed ID: 7913419
[TBL] [Abstract][Full Text] [Related]
30. Prognostic impact of mutated K-ras gene in surgically resected non-small cell lung cancer patients.
Rosell R; Li S; Skacel Z; Mate JL; Maestre J; Canela M; Tolosa E; Armengol P; Barnadas A; Ariza A
Oncogene; 1993 Sep; 8(9):2407-12. PubMed ID: 8395679
[TBL] [Abstract][Full Text] [Related]
31. Detection of K-ras point mutation by enriched PCR-colorimetric plate assay.
Santiago FS; Todd AV; Hawkins NJ; Ward RL
Mol Cell Probes; 1997 Feb; 11(1):33-8. PubMed ID: 9076712
[TBL] [Abstract][Full Text] [Related]
32. K-ras gene mutation is a useful predictor of the survival of early stage colorectal cancers.
Lee JC; Wang ST; Lai MD; Lin YJ; Yang HB
Anticancer Res; 1996; 16(6B):3839-44. PubMed ID: 9042267
[TBL] [Abstract][Full Text] [Related]
33. Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.
Vachtenheim J; Horáková I; Novotná H; Opáalka P; Roubková H
Clin Cancer Res; 1995 Mar; 1(3):359-65. PubMed ID: 9815992
[TBL] [Abstract][Full Text] [Related]
34. K-ras activation in premalignant and malignant epithelial lesions of the human uterus.
Enomoto T; Inoue M; Perantoni AO; Buzard GS; Miki H; Tanizawa O; Rice JM
Cancer Res; 1991 Oct; 51(19):5308-14. PubMed ID: 1913654
[TBL] [Abstract][Full Text] [Related]
35. A subset of lung adenocarcinomas and atypical adenomatous hyperplasia-associated foci are genotypically related: an EGFR, HER2, and K-ras mutational analysis.
Sartori G; Cavazza A; Bertolini F; Longo L; Marchioni A; Costantini M; Barbieri F; Migaldi M; Rossi G
Am J Clin Pathol; 2008 Feb; 129(2):202-10. PubMed ID: 18208799
[TBL] [Abstract][Full Text] [Related]
36. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer.
Jiang W; Kahn SM; Guillem JG; Lu SH; Weinstein IB
Oncogene; 1989 Jul; 4(7):923-8. PubMed ID: 2666911
[TBL] [Abstract][Full Text] [Related]
37. Oncogene alterations in primary human colon tumors.
Alexander RJ; Buxbaum JN; Raicht RF
Gastroenterology; 1986 Dec; 91(6):1503-10. PubMed ID: 2876925
[TBL] [Abstract][Full Text] [Related]
38. Differential activation of ras genes by point mutation in human colon cancer with metastases to either lung or liver.
Oudejans JJ; Slebos RJ; Zoetmulder FA; Mooi WJ; Rodenhuis S
Int J Cancer; 1991 Dec; 49(6):875-9. PubMed ID: 1959991
[TBL] [Abstract][Full Text] [Related]
39. Sensitive and specific detection of K-ras mutations in colon tumors by short oligonucleotide mass analysis.
Lleonart ME; Ramón y Cajal S; Groopman JD; Friesen MD
Nucleic Acids Res; 2004 Mar; 32(5):e53. PubMed ID: 15037663
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine.
Nishiyama K; Yao T; Yonemasu H; Yamaguchi K; Tanaka M; Tsuneyoshi M
Oncol Rep; 2002; 9(2):293-300. PubMed ID: 11836595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
